RISKS AND BENEFITS OF METHYLXANTHINES THERAPY – CASE STUDY
Introduction. Apnea of prematurity (AOP), a developmental disorder of respiratory control present in approximately 80% of extremely low birth weight (ELBW) infants, that, if prolonged, may cause hypoxemia and low cardiac output, with subsequent neurodevelopmental compromise. Material and method. R...
Main Authors: | Mariana Boia, Delia Maria Nicoar, Aniko Maria Manea |
---|---|
Format: | Article |
Language: | English |
Published: |
Amaltea Medical Publishing House
2014-09-01
|
Series: | Romanian Journal of Pediatrics |
Subjects: | |
Online Access: | https://revistemedicale.amaltea.ro/Romanian_Journal_of_PEDIATRICS/Revista_Romana_de_PEDIATRIE-2014-Nr.3/EN/RJP_2014_3_EN_Art-04.pdf |
Similar Items
-
Prospective Survey on Safety Evaluation of Injectable Methylxanthines in Japan
by: Ken Ohta, et al.
Published: (2006-01-01) -
Caffeine Administration to Prevent Apnea in Very Premature Infants
by: Amir-Mohammad Armanian, et al.
Published: (2016-10-01) -
Methylxanthines accumulation in Ilex species - caffeine and theobromine in erva-mate (Ilex paraguariensis) and other Ilex species
by: Reginatto F.H., et al.
Published: (1999-01-01) -
Anti-obesity potential of natural methylxanthines
by: David F. Carrageta, et al.
Published: (2018-04-01) -
Methylxanthines and Neurodegenerative Diseases: An Update
by: Daniel Janitschke, et al.
Published: (2021-02-01)